2020
DOI: 10.1016/j.medcle.2019.06.020
|View full text |Cite
|
Sign up to set email alerts
|

Simplified medication regimen and survival in polypathological patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 28 publications
1
1
0
Order By: Relevance
“…The total number of readmissions within 12 months was initially signi cantly higher in those with high MRCI and elevated Charlson comorbidity index and polypharmacy compared to those with low MRCI and it was more predominant among the Qatari population compared to other nationalities, but again this was non-signi cant after adjusting other variables. In our study, although the mortality rate was not statistically signi cantly higher in the high MRCI group, it may be of clinical signi cance, which may con rm the results of the previously published study that concluded higher survival rate in elderly patients with simpli ed regimen compared to those with complex regimen [33]. The previously published studies investigating MRCI had focused on elderly patients with multiple co-morbidities, polypharmacy, and subsequently higher medication regimen complexity [34,35].…”
Section: Discussionsupporting
confidence: 83%
“…The total number of readmissions within 12 months was initially signi cantly higher in those with high MRCI and elevated Charlson comorbidity index and polypharmacy compared to those with low MRCI and it was more predominant among the Qatari population compared to other nationalities, but again this was non-signi cant after adjusting other variables. In our study, although the mortality rate was not statistically signi cantly higher in the high MRCI group, it may be of clinical signi cance, which may con rm the results of the previously published study that concluded higher survival rate in elderly patients with simpli ed regimen compared to those with complex regimen [33]. The previously published studies investigating MRCI had focused on elderly patients with multiple co-morbidities, polypharmacy, and subsequently higher medication regimen complexity [34,35].…”
Section: Discussionsupporting
confidence: 83%
“…Previous findings show that MRCI is correlated with health outcomes, specifically prognosis (of diabetes and hepatocellular carcinoma) but also mortality [ 21 ]. Two different studies utilized registry data and hospital records to show that high MRCI scores were associated with higher 4-year mortality, and higher odds of mortality (adjusted odds ratio = 1.12) [ 22 , 23 ], respectively. A recent study showed that higher MRCI was associated with increased mortality, a longer ICU length of stay (LOS), and the need for mechanical ventilation (MV) [ 17 ].…”
Section: Introductionmentioning
confidence: 99%